PROM1 and central nervous system cancer: In line with this, Wei et al. (2022) reported that CD133 C-terminal domain interaction with DNMT1 (DNA methyltransferase 1) depends on CD133 glycosylation status in glioma stem-like cells (GSCs) [24].